Philip Morris Limited Launches Delia to Expand IQOS Iluma Consumables Portfolio

Apr.03
Philip Morris Limited Launches Delia to Expand IQOS Iluma Consumables Portfolio
Philip Morris Limited has announced the launch of Delia, the latest addition to its portfolio of heated tobacco and zero-tobacco sticks exclusively compatible with the IQOS Iluma range.

Special statement:

This article is for internal industry communication only and does not make any recommendations for specific brands or products.

The images presented in this article are only used to describe the facts and are not intended as advertisements for any products.

Minors are prohibited from accessing this article.


Key Takeaways

 

  • Philip Morris Limited has launched Delia, exclusively compatible with the IQOS Iluma range.
  • Delia joins the existing Terea tobacco sticks and Levia zero-tobacco sticks.
  • The range includes three SKUs: Full Flavour, Balanced and Menthol.
  • Delia uses a streamlined pack format inspired by traditional cigarettes.
  • Delia has a recommended retail price of GBP 6 (approximately USD 7.80, based on 1 GBP ≈ 1.30 USD).

 


 

2Firsts, April 1, 2026

 

According to Convenience Store, Philip Morris Limited (PML) has launched Delia, the latest addition to its growing portfolio of heated tobacco and zero-tobacco sticks, exclusively compatible with the IQOS Iluma range.

 

Delia joins Terea and Levia to expand the IQOS Iluma consumables portfolio

 

PML said Delia joins the existing Terea tobacco sticks and Levia zero-tobacco sticks. The company said Delia was developed to “broaden consumer choice and better cater to adult smokers seeking a more classic tobacco experience.”

 

PML also said the range is particularly suited to adult smokers who value ritual, simplicity and an authentic tobacco experience.

 

The new range includes three variants and adopts a cigarette-inspired pack format

 

The Delia range includes three SKUs spanning Full Flavour, Balanced and Menthol variants. PML said this provides clear and intuitive choices for adult users.

 

The company said the range uses simple, non-aromatic flavour profiles and has been carefully developed to complement the existing portfolio.

 

Delia also introduces a streamlined, cigarette-inspired pack format. PML said the design is intended to minimise disruption in routine and make it easier for adult smokers to navigate and purchase the product.

 

Delia is priced at GBP 6, creating a new price tier within the IQOS Iluma consumables range

 

PML said Delia has a recommended retail price of GBP 6 (approximately USD 7.80, based on 1 GBP ≈ 1.30 USD), creating a new price tier within the IQOS Iluma consumables portfolio.

 

Anthony Loinsard, head of IQOS at PML, said Delia creates a new opportunity for retailers to attract price-sensitive adult smokers while supporting retention within the heated tobacco category.

 

He also said that by broadening choice within the IQOS Iluma consumables range, retailers are given more opportunity to engage different shopper missions and drive value in the category.

 

Image credit: Convenience Store

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

American Snuff Expands Manufacturing Hiring as Reynolds American Builds Future-Ready Operations
American Snuff Expands Manufacturing Hiring as Reynolds American Builds Future-Ready Operations
Reynolds American said American Snuff Company will add more than 50 manufacturing roles at its Clarksville, Tennessee facility as part of its wider U.S. manufacturing investment plan. The company said the hiring is one of the latest developments under its plan to invest more than USD 3.2 billion across U.S. operations by 2030.
Mar.27 by 2FIRSTS.ai
Cyprus Bill to Regulate Nicotine Pouches Expected to Reach House Plenary in Early April
Cyprus Bill to Regulate Nicotine Pouches Expected to Reach House Plenary in Early April
A proposed law to regulate nicotine pouches in Cyprus is expected to reach the House plenary session in early April. The bill, submitted by Diko MP Chrysis Pantelidis, aims to establish a regulatory framework governing the marketing, composition and quality of nicotine pouches currently circulating on the market and to incorporate them into existing smoking control legislation.
Mar.13 by 2FIRSTS.ai
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
A study using 2020–2023 U.S. data from the ITC Youth Tobacco and Vaping Survey (ages 16–19) reports that both nicotine/tobacco use and internalizing mental health (IMH) symptoms vary across disaggregated gender identities, and that gender identity moderates the relationship between IMH symptoms and product use.
Feb.27 by 2FIRSTS.ai
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
A new study by the Fraunhofer Institute says the rapidly expanding illicit market for disposable e-cigarettes is undermining European regulation, fuelling youth vaping and causing significant tax losses. The study says the illicit market is worth EUR 6.6 billion in 2026 and is projected to rise to EUR 10.8 billion by 2030. It adds that a significant share of the disposable vape market now operates outside the regulatory framework established by the EU Tobacco Products Directive.
Mar.13 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24